bioRxivCancer BiologyPreprint
Metabolic Salvage and Acyl-chain Remodeling Support Glycosphingolipid Synthesis within the PDAC Tumor Microenvironment
Anna TrimbleiD, Casie S. KubotaiD, Elaine Zhao, Maureen L. RuchhoeftiD, Jonathan WeitziD, Woncheol JungiD, Kristina L. PeckiD, Satoshi OgawaiD, Ethan L. AshleyiD, Hervé TiriaciD, Tae Gyu OhiD, Andrew M. LowyiD, Dannielle D. EngleiD, Christian M. MetalloiD
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy where metabolic homeostasis is maintained by tumor and stromal cells within the tumor microenvironment (TME). To better assess pathways supporting macromolecule biosynthesis in PDAC tumors, we apply 13C metabolic flux analysis (MFA) to slice cultures of treatment-naive human tumors and mouse models that retain the native TME. Glycans, lipid headgroups, and very long-chain fatty acids are the most dynamic metabolic pools, while long chain fatty acids, purines, and pyrimidines are predominantly salvaged locally in situ. We use targeted pharmacological modulators to highlight the importance of recycling pathways and metabolic redundancies which mitigate changes in lipid abundances. Finally, we leverage targeted lipid fluxomics and the distinct ganglioside and globoside profiles of tumor and stromal cells, respectively, to demonstrate the role of the lipid kinase PIKfyve in supporting ganglioside homeostasis via sialic acid and ceramide salvage. These data establish application of MFA to slice cultures of PDAC tumors as an effective approach for assessing metabolic mechanisms and therapeutic responses within an intact TME.
- organism: human
- organism: mouse
- assay: bulk RNA-seq
- research focus: metabolism & bioenergetics
- research focus: cell type annotation
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancer
Caleb Cheng, Jing Hu, … Arul M. Chinnaiyan·NaturePeer-reviewed·Apr 23, 2025
- KRAS-driven metabolic reprogramming of enhanced MFSD2A-mediated lysophosphatidylcholine scavenging promotes survival and progression of pancreatic ductal adenocarcinoma
Yihui Chen, Cason Haffner, … Johannes Francois Fahrmann·bioRxiv·Oct 6, 2026
- Exploring the metabolic landscape of pancreatic ductal adenocarcinoma cells using genome-scale metabolic modeling
Mohammad Mazharul Islam, Andrea Goertzen, … Rajib Saha·iSciencePeer-reviewed·May 30, 2022
- Co-targeting an AMPK--MAPK axis reprograms CAFs and suppresses PDAC
Ryodai Yamamura, Yusuke Satoh, … Masahiro Sonoshita·bioRxiv·Mar 18, 2026
- Targeting de novo lipogenesis improves gemcitabine efficacy in pancreatic ductal adenocarcinoma
Sarah E. Hancock, Linda L. Garthwaite, … Nigel A. Turner·bioRxiv·Dec 18, 2024
- PP2A activation drives aberrant macropinocytosis and cell death in pancreatic ductal adenocarcinoma
Garima Baral, Claire M. Pfeffer, … Brittany L. Allen-Petersen·bioRxiv·Jul 14, 2025